Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Well-differentiated Neuroendocrine Pulmonary Tumors (NETp) are morphologically classified as Typical (TC) and Atypical Carcinoid (AC).
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Tanaka H
Authors: Tanaka H, Petrocchi Corassa M, Carioca Freitas H, José de Barros e Silva M, Riechelmann R,
Keywords: Atypical Carcinoid, Typical Carcinoid, Neuroendocrine Pulmonary Tumors,
Introduction: Patients with metastatic small-intestinal neuroendocrine tumours (NET) have been shown to have a reduced quality of life compared to the general population and many have disabling symptoms during somatostatin analogue (SSA) treatment.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Sorbye H
Authors: Sorbye H, Meyer L, Mordal K, Myhre S, Thiis-Evensen E,
Keywords: Quality of life, small-intestinal neuroendocrine tumors, patient reported symptoms, coping, somatostatin analogue,
#2700 Pancreatic Neuroendocrine Neoplasms and Liver Metastases: When Size Matters
Introduction: Small non-functioning pNENs are low grade indolent tumors, however distant metastases have also been documented in this subset of patients
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Monteleone M, Rossi R, Altomare M, Prinzi N, Cattaneo L,
Keywords: Pancreatic neuroendocrine neoplasia, Liver metastases,
Introduction: The presence of CTCs confers adverse prognosis in metastatic NET pts with heterogenous treatment history. Post treatment CTC count correlates with disease progression and overall survival.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Meyer T
Authors: Meyer T, Higgs K, Hickling M, Houchard A,
Keywords: midgut neuroendocrine tumor, CTC, lanreotide,
Introduction: Cell-free DNA (cfDNA) as a type of “liquid biopsy” represents an attractive alternative to tissue sampling for detecting tumour-specific changes (circulating tumour DNA; ctDNA).
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Pipinikas C
Authors: Pipinikas C, Gutteridge A, Forshew T, Childs A, Meyer T,